463 related articles for article (PubMed ID: 8943519)
21. Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel.
Rogers PA; Au CL; Affandi B
Hum Reprod; 1993 Sep; 8(9):1396-404. PubMed ID: 8253925
[TBL] [Abstract][Full Text] [Related]
22. A review of the endometrial changes in Norplant users.
Wan LS
Ann N Y Acad Sci; 1997 Sep; 828():108-10. PubMed ID: 9329828
[TBL] [Abstract][Full Text] [Related]
23. A three-dimensional study of endometrial microvessels in women using the contraceptive subdermal levonorgestrel implant system, norplant.
Simbar M; Manconi F; Markham R; Hickey M; Fraser IS
Micron; 2004; 35(7):589-95. PubMed ID: 15219905
[TBL] [Abstract][Full Text] [Related]
24. The effects of levonorgestrel implants on vascular endothelial growth factor expression in the endometrium.
Lau TM; Affandi B; Rogers PA
Mol Hum Reprod; 1999 Jan; 5(1):57-63. PubMed ID: 10050663
[TBL] [Abstract][Full Text] [Related]
25. Surface vascularization and endometrial appearance in women with menorrhagia or using levonorgestrel contraceptive implants. Implications for the mechanisms of breakthrough bleeding.
Hickey M; Fraser IS
Hum Reprod; 2002 Sep; 17(9):2428-34. PubMed ID: 12202436
[TBL] [Abstract][Full Text] [Related]
26. Timing of onset of contraceptive effectiveness in Norplant implant users. Part I. Changes in cervical mucus.
Dunson TR; Blumenthal PD; Alvarez F; Brache V; Cochon L; Dalberth B; Glover L; Remsburg R; Vu K; Katz D
Fertil Steril; 1998 Feb; 69(2):258-66. PubMed ID: 9496339
[TBL] [Abstract][Full Text] [Related]
27. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
[TBL] [Abstract][Full Text] [Related]
28. The measurement of endometrial perfusion in norplant users: a pilot study.
Hickey M; Carati C; Manconi F; Gannon BJ; Dwarte D; Fraser IS
Hum Reprod; 2000 May; 15(5):1086-91. PubMed ID: 10783358
[TBL] [Abstract][Full Text] [Related]
29. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery.
Critchley HO; Wang H; Jones RL; Kelly RW; Drudy TA; Gebbie AE; Buckley CH; McNeilly AS; Glasier AF
Hum Reprod; 1998 May; 13(5):1218-24. PubMed ID: 9647550
[TBL] [Abstract][Full Text] [Related]
30. Basement membrane components in normal hyperplastic and neoplastic endometrium.
Bulletti C; Galassi A; Jasonni VM; Martinelli G; Tabanelli S; Flamigni C
Cancer; 1988 Jul; 62(1):142-9. PubMed ID: 3383111
[TBL] [Abstract][Full Text] [Related]
31. Oestrogen treatment for increased bleeding in Norplant users: preliminary results.
Witjaksono J; Lau TM; Affandi B; Rogers PA
Hum Reprod; 1996 Oct; 11 Suppl 2():109-14. PubMed ID: 8982752
[TBL] [Abstract][Full Text] [Related]
32. A 2-year comparative study of endometrial histology and cervical cytology of contraceptive implant users in Birmingham, UK.
Mascarenhas L; van Beek A; Bennink HC; Newton J
Hum Reprod; 1998 Nov; 13(11):3057-60. PubMed ID: 9853856
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical sex steroid receptor distribution in endometrium from long-term subdermal levonorgestrel users and during the normal menstrual cycle.
Critchley HO; Bailey DA; Au CL; Affandi B; Rogers PA
Hum Reprod; 1993 Oct; 8(10):1632-9. PubMed ID: 8300819
[TBL] [Abstract][Full Text] [Related]
34. Morphometric study of the human endometrium following continuous exposure to levonorgestrel released from vaginal rings during 90 days.
Johannisson E; Brosens I; Cornillie F; Elder M; White J; Sheppard B; Hourihan H; d'Arcangues C; Belsey EM
Contraception; 1991 Apr; 43(4):361-74. PubMed ID: 1906792
[TBL] [Abstract][Full Text] [Related]
35. Effect of switching with oral contraceptives.
Wassef SA; Sami G; Hamid EA
Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):77-93. PubMed ID: 12254511
[TBL] [Abstract][Full Text] [Related]
36. The effects of reformulated 2-rod Norplant implant on hemostasis after three years.
Viegas OA; Koh SC; Ratnam SS
Contraception; 1996 Oct; 54(4):219-28. PubMed ID: 8922875
[TBL] [Abstract][Full Text] [Related]
37. Precise measurements of intrauterine vascular structures at hysteroscopy in menorrhagia and during Norplant use.
Hickey M; Dwarte D; Fraser IS
Hum Reprod; 1998 Nov; 13(11):3190-6. PubMed ID: 9853879
[TBL] [Abstract][Full Text] [Related]
38. Endometrial vascular features prior to and following exposure to levonorgestrel.
Hourihan HM; Sheppard BL; Belsey EM; Brosens IA
Contraception; 1991 Apr; 43(4):375-85. PubMed ID: 1906793
[TBL] [Abstract][Full Text] [Related]
39. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
[TBL] [Abstract][Full Text] [Related]
40. The ultrastructure of human endometrium is altered by administration of intrauterine levonorgestrel.
Pakarinen PI; Lähteenmäki P; Lehtonen E; Reima I
Hum Reprod; 1998 Jul; 13(7):1846-53. PubMed ID: 9740437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
